ArticlePain2025
A glutamatergic brain neural circuit is critical for modulating trigeminal neuropathic pain.
Article in Pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Trigeminal neuralgia: from clinical challenges to molecular insights.The journal of headache and pain · 2026Review
- The excitatory neurotransmitter glutamate and its receptors: the culprits behind neuropathic pain?Frontiers in aging neuroscience · 2026Review
- The relationship between abnormal glucose metabolism and chronic pain.Cell & bioscience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
abstractTrigeminal neuropathic pain is a predominant symptom in patients with trigeminal neuralgia. However, the underlying neural circuit mechanism is still elusive. In this study, we investigated the role of a brain neural circuit in the modulation of trigeminal neuropathic pain. We used "Targeted Recombination in Active Populations" to identify activated neurons in brain structures. Anterograde and retrograde viral tracing combined with immunofluorescence staining was used to validate the activated neurons-involved neuronal pathway. We performed optogenetic stimulation and behavioral observation to dissect the brain neural circuitry that underlies the modulation of trigeminal neuropathic pain. We further conducted dual-color fiber photometry to analyze dynamic neurotransmitter release and real-time neuronal activity while observing pain behaviors simultaneously. We observed that mouse neurons in the anterior paraventricular nucleus of thalamus were activated specifically by chronic constriction injury of the infraorbital nerve. We further observed that specifical excitation or silencing of the activated neurons bidirectionally modulated the nerve injury-caused trigeminal neuropathic pain in mice. More importantly, optogenetic activation of the brain neural circuit from anterior paraventricular nucleus of thalamus to anterior cingulate cortex exacerbated such pain and this effect was blocked by an N -methyl- d -aspartate receptor antagonist. Meanwhile, optogenetic activation of this neural circuit markedly increased glutamate release and enhanced neuronal activity in the anterior cingulate cortex. Our results suggest that the identified brain neural circuit could be targeted to develop a novel neuromodulation therapy for trigeminal neuropathic pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.